Cargando…

Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM

Objective: The aim of this study was to systematically explore the pyrrolizidine alkaloids (PAs) type, content and risk assessment in the three Boraginaceae used in TCM, involving Arnebia euchroma (AE), A. guttata (AG), and Lithospermum erythrorhizon (LE). Method: A UHPLC–MS/MS method was establishe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zan, Ke, Wang, Zhao, Hu, Xiao-Wen, Li, Yao-Lei, Wang, Ying, Jin, Hong-Yu, Zuo, Tian-Tian, Ma, Shuang-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076571/
https://www.ncbi.nlm.nih.gov/pubmed/37033649
http://dx.doi.org/10.3389/fphar.2023.1075010
_version_ 1785020156504702976
author Zan, Ke
Wang, Zhao
Hu, Xiao-Wen
Li, Yao-Lei
Wang, Ying
Jin, Hong-Yu
Zuo, Tian-Tian
Ma, Shuang-Cheng
author_facet Zan, Ke
Wang, Zhao
Hu, Xiao-Wen
Li, Yao-Lei
Wang, Ying
Jin, Hong-Yu
Zuo, Tian-Tian
Ma, Shuang-Cheng
author_sort Zan, Ke
collection PubMed
description Objective: The aim of this study was to systematically explore the pyrrolizidine alkaloids (PAs) type, content and risk assessment in the three Boraginaceae used in TCM, involving Arnebia euchroma (AE), A. guttata (AG), and Lithospermum erythrorhizon (LE). Method: A UHPLC–MS/MS method was established to simultaneously determine eight pyrrolizidine alkaloids (PAs), namely intermedine, lycopsamine, intermedine N-oxide, lycopsamine N-oxide, 7-acetyllycopsamine, 7-acetyllycopsamine N-oxide, echimidine N-oxide, and echimidine in the three herbs. Based on these results, the risk assessment was explored using the routine margin of exposure (MOE) combined with relative potency (REP) for oral and external usage, respectively. Results and Conclusion: Imermedine and imermedine N-oxide were common components in the eight tested PAs. 7-acetyllycopsamine and its N-oxide were not detected in AE; echimidine and its N-oxide were not detected in AG; lycopsamine and its N-oxide, 7-acetyllycopsamine and its N-oxide were not detected in LE. The total contents of 8 PAs in 11 batches of AG was341.56–519.51 μg/g; the content in 15 batches of LE was 71.16–515.73 μg/g, and the content in 11 batches of AE was 23.35–207.13 μg/g. Based on these results, the risk assessment was explored using MOE combined with REP for oral and external usage, respectively. The findings of the risk assessment method of PAs based on MOE combined with the REP factor were consistent with the clinical toxicity results. As an oral herb, AE had low risk or no risk due to its low PA contents, and individual batches of LE were medium risk, while attention should be paid to their clinical use.AG was also low risk. The external use of the three Boraginaceae used in TCM was not associated with any risk. This study systematically explored the PA type and content of the three Boraginaceae used in TCM. Additionally, the refined risk assessment of PAs based on REP provided a more scientific basis for quality evaluation and rational use of the medicinal Boraginaceae used in TCM to improve public health.
format Online
Article
Text
id pubmed-10076571
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100765712023-04-07 Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM Zan, Ke Wang, Zhao Hu, Xiao-Wen Li, Yao-Lei Wang, Ying Jin, Hong-Yu Zuo, Tian-Tian Ma, Shuang-Cheng Front Pharmacol Pharmacology Objective: The aim of this study was to systematically explore the pyrrolizidine alkaloids (PAs) type, content and risk assessment in the three Boraginaceae used in TCM, involving Arnebia euchroma (AE), A. guttata (AG), and Lithospermum erythrorhizon (LE). Method: A UHPLC–MS/MS method was established to simultaneously determine eight pyrrolizidine alkaloids (PAs), namely intermedine, lycopsamine, intermedine N-oxide, lycopsamine N-oxide, 7-acetyllycopsamine, 7-acetyllycopsamine N-oxide, echimidine N-oxide, and echimidine in the three herbs. Based on these results, the risk assessment was explored using the routine margin of exposure (MOE) combined with relative potency (REP) for oral and external usage, respectively. Results and Conclusion: Imermedine and imermedine N-oxide were common components in the eight tested PAs. 7-acetyllycopsamine and its N-oxide were not detected in AE; echimidine and its N-oxide were not detected in AG; lycopsamine and its N-oxide, 7-acetyllycopsamine and its N-oxide were not detected in LE. The total contents of 8 PAs in 11 batches of AG was341.56–519.51 μg/g; the content in 15 batches of LE was 71.16–515.73 μg/g, and the content in 11 batches of AE was 23.35–207.13 μg/g. Based on these results, the risk assessment was explored using MOE combined with REP for oral and external usage, respectively. The findings of the risk assessment method of PAs based on MOE combined with the REP factor were consistent with the clinical toxicity results. As an oral herb, AE had low risk or no risk due to its low PA contents, and individual batches of LE were medium risk, while attention should be paid to their clinical use.AG was also low risk. The external use of the three Boraginaceae used in TCM was not associated with any risk. This study systematically explored the PA type and content of the three Boraginaceae used in TCM. Additionally, the refined risk assessment of PAs based on REP provided a more scientific basis for quality evaluation and rational use of the medicinal Boraginaceae used in TCM to improve public health. Frontiers Media S.A. 2023-03-23 /pmc/articles/PMC10076571/ /pubmed/37033649 http://dx.doi.org/10.3389/fphar.2023.1075010 Text en Copyright © 2023 Zan, Wang, Hu, Li, Wang, Jin, Zuo and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zan, Ke
Wang, Zhao
Hu, Xiao-Wen
Li, Yao-Lei
Wang, Ying
Jin, Hong-Yu
Zuo, Tian-Tian
Ma, Shuang-Cheng
Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
title Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
title_full Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
title_fullStr Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
title_full_unstemmed Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
title_short Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
title_sort pyrrolizidine alkaloids and health risk of three boraginaceae used in tcm
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076571/
https://www.ncbi.nlm.nih.gov/pubmed/37033649
http://dx.doi.org/10.3389/fphar.2023.1075010
work_keys_str_mv AT zanke pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm
AT wangzhao pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm
AT huxiaowen pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm
AT liyaolei pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm
AT wangying pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm
AT jinhongyu pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm
AT zuotiantian pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm
AT mashuangcheng pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm